A. London

发表

Concurrent Assessment of Hepatic and Intestinal Cytochrome P450 3A Activities Using Deuterated Alfentanil

S. Vangveravong, E. Kharasch, J. Blood, 2011, Clinical pharmacology and therapeutics.

Mechanism of Efavirenz Influence on Methadone Pharmacokinetics and Pharmacodynamics

D. Whittington, E. Kharasch, S. Campbell, 2012, Clinical pharmacology and therapeutics.

Tony Gin Pharmacokinetics and Tissue Penetration of Cefoxitin in Obesity : Implications for Risk of Surgical Site Infection

E. Kharasch, M. Mutch, A. Stefanescu, 2012 .

Pharmacokinetics and Tissue Penetration of Cefoxitin in Obesity: Implications for Risk of Surgical Site Infection

E. Kharasch, M. Mutch, A. Stefanescu, 2011, Anesthesia and analgesia.

Perioperative pharmacokinetics of methadone in adolescents.

E. Kharasch, Anshuman Sharma, Thomas Kim, 2011, Anesthesiology.

Urinary biomarkers for the early diagnosis of kidney cancer.

E. Kharasch, J. Morrissey, A. London, 2010, Mayo Clinic proceedings.

Simultaneous determination of alfentanil and midazolam in human plasma using liquid chromatography and tandem mass spectrometry.

E. Kharasch, Thomas Kim, A. London, 2011, Journal of pharmaceutical and biomedical analysis.

Sensitivity and Specificity of Urinary Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 for the Diagnosis of Renal Cell Carcinoma

E. Kharasch, J. Morrissey, A. London, 2011, American Journal of Nephrology.

Sensitivity of Intravenous and Oral Alfentanil and Pupillary Miosis as Minimal and Noninvasive Probes for Hepatic and First‐Pass CYP3A Induction

E. Kharasch, Thomas Kim, J. Blood, 2011, Clinical pharmacology and therapeutics.

Sensitivity and Specificity of Urinary Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 for the Diagnosis of Renal Cell Carcinoma

E. Kharasch, J. Morrissey, A. London, 2011, American Journal of Nephrology.